228 related articles for article (PubMed ID: 24383792)
1. Range modulation in proton therapy planning: a simple method for mitigating effects of increased relative biological effectiveness at the end-of-range of clinical proton beams.
Buchsbaum JC; McDonald MW; Johnstone PA; Hoene T; Mendonca M; Cheng CW; Das IJ; McMullen KP; Wolanski MR
Radiat Oncol; 2014 Jan; 9():2. PubMed ID: 24383792
[TBL] [Abstract][Full Text] [Related]
2. Microdosimetric calculation of relative biological effectiveness for design of therapeutic proton beams.
Kase Y; Yamashita W; Matsufuji N; Takada K; Sakae T; Furusawa Y; Yamashita H; Murayama S
J Radiat Res; 2013 May; 54(3):485-93. PubMed ID: 23179376
[TBL] [Abstract][Full Text] [Related]
3. Relative biological effectiveness (RBE) values for proton beam therapy.
Paganetti H; Niemierko A; Ancukiewicz M; Gerweck LE; Goitein M; Loeffler JS; Suit HD
Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):407-21. PubMed ID: 12023146
[TBL] [Abstract][Full Text] [Related]
4. Significance and implementation of RBE variations in proton beam therapy.
Paganetti H
Technol Cancer Res Treat; 2003 Oct; 2(5):413-26. PubMed ID: 14529306
[TBL] [Abstract][Full Text] [Related]
5. Towards proton arc therapy: physical and biologically equivalent doses with increasing number of beams in pediatric brain irradiation.
Toussaint L; Indelicato DJ; Holgersen KS; Petersen JBB; Stokkevåg CH; Lassen-Ramshad Y; Casares-Magaz O; Vestergaard A; Muren LP
Acta Oncol; 2019 Oct; 58(10):1451-1456. PubMed ID: 31303090
[No Abstract] [Full Text] [Related]
6. Proton Treatment Techniques for Posterior Fossa Tumors: Consequences for Linear Energy Transfer and Dose-Volume Parameters for the Brainstem and Organs at Risk.
Giantsoudi D; Adams J; MacDonald SM; Paganetti H
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):401-410. PubMed ID: 27986346
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of dynamic adaptive passive scattering proton therapy with computed tomography image guidance in the lung.
Moriya S; Tachibana H; Hotta K; Nakamura N; Sakae T; Akimoto T
Med Phys; 2017 Sep; 44(9):4474-4481. PubMed ID: 28665491
[TBL] [Abstract][Full Text] [Related]
8. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
Rana S; Zheng Y
J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
[TBL] [Abstract][Full Text] [Related]
9. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios.
Giovannini G; Böhlen T; Cabal G; Bauer J; Tessonnier T; Frey K; Debus J; Mairani A; Parodi K
Radiat Oncol; 2016 May; 11():68. PubMed ID: 27185038
[TBL] [Abstract][Full Text] [Related]
10. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
[TBL] [Abstract][Full Text] [Related]
11. Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges.
Hahn C; Heuchel L; Ödén J; Traneus E; Wulff J; Plaude S; Timmermann B; Bäumer C; Lühr A
Radiat Oncol; 2022 Oct; 17(1):169. PubMed ID: 36273132
[TBL] [Abstract][Full Text] [Related]
12. Nuclear interactions in proton therapy: dose and relative biological effect distributions originating from primary and secondary particles.
Paganetti H
Phys Med Biol; 2002 Mar; 47(5):747-64. PubMed ID: 11931469
[TBL] [Abstract][Full Text] [Related]
13. Range uncertainty in proton therapy due to variable biological effectiveness.
Carabe A; Moteabbed M; Depauw N; Schuemann J; Paganetti H
Phys Med Biol; 2012 Mar; 57(5):1159-72. PubMed ID: 22330133
[TBL] [Abstract][Full Text] [Related]
14. Considerations for shoot-through FLASH proton therapy.
Verhaegen F; Wanders RG; Wolfs C; Eekers D
Phys Med Biol; 2021 Mar; 66(6):06NT01. PubMed ID: 33571981
[TBL] [Abstract][Full Text] [Related]
15. Enhanced radiobiological effects at the distal end of a clinical proton beam: in vitro study.
Matsumoto Y; Matsuura T; Wada M; Egashira Y; Nishio T; Furusawa Y
J Radiat Res; 2014 Jul; 55(4):816-22. PubMed ID: 24824674
[TBL] [Abstract][Full Text] [Related]
16. Variations in the RBE for cell killing along the depth-dose profile of a modulated proton therapy beam.
Britten RA; Nazaryan V; Davis LK; Klein SB; Nichiporov D; Mendonca MS; Wolanski M; Nie X; George J; Keppel C
Radiat Res; 2013 Jan; 179(1):21-8. PubMed ID: 23148508
[TBL] [Abstract][Full Text] [Related]
17. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
Ödén J; Eriksson K; Toma-Dasu I
Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
[TBL] [Abstract][Full Text] [Related]
18. The influence of breathing motion and a variable relative biological effectiveness in proton therapy of left-sided breast cancer.
Ödén J; Toma-Dasu I; Eriksson K; Flejmer AM; Dasu A
Acta Oncol; 2017 Nov; 56(11):1428-1436. PubMed ID: 28826308
[TBL] [Abstract][Full Text] [Related]
19. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
Traneus E; Ödén J
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
[TBL] [Abstract][Full Text] [Related]
20. Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study.
Liu G; Li X; Qin A; Zheng W; Yan D; Zhang S; Stevens C; Kabolizadeh P; Ding X
Radiat Oncol; 2020 Jan; 15(1):21. PubMed ID: 32000817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]